Abstract
Background Most physical activity interventions adopt a one-size-fits-all approach, often developed and tested in higher socioeconomic groups, with little consideration of barriers experienced by women from lower socioeconomic backgrounds. Micropatterns, defined as brief bursts of moderate-to-vigorous incidental physical activity lasting under three minutes, represent a form of everyday movement that requires minimal time, equipment, or planning, making them a promising target for intervention. This randomized controlled study evaluated the feasibility, acceptability and potential effectiveness of a co-designed wearable-based micropatterns intervention aimed at increasing moderate-to-vigorous physical activity (MVPA) among socioeconomically diverse women.
Methods
A multi-centre, single-blinded, 6-week randomised controlled feasibility study was conducted among women from Sydney, Australia and Glasgow, UK aged ≥30 years who self-reported no leisure time physical activity and could comfortably participate in activities of daily living. To ensure socioeconomic diversity, we used quota-based recruitment with area-level and individual-level indicators of socioeconomic status. Participants were randomised to one of three intervention arms; 1) Smartphone application only (APP); 2) smartphone application combined with a wearable device (Fitbit Inspire 3; W-APP); and 3) smartphone application and wearable device, supplemented by a social community component that included two in-person workshops and online forums (W-APP-C). Feasibility was assessed as completion rates of the study and follow-up surveys were conducted to assess the acceptability of the intervention. Wrist-worn accelerometry was collected at pre- and post-intervention to assess the potential effectiveness of the intervention.
Results
Forty-three participants (mean age (SD); 54.8 (10.7) years) were recruited across both sites (APP n = 13; W-APP n = 17; W-APP-C n = 13). When taking into consideration individual-level indicators of socioeconomic status including income, number of dependents, and educational attainment, there was diverse representation across low (20.9%), medium (48.8%), and high (30.2%) socioeconomic groups. Completion of the 6-week intervention was high across both intervention sites and all three trial arms (86%). Qualitative feedback from both trial sites indicated high satisfaction, the majority of the participants thought the intervention was enjoyable (97.9%), user-friendly (69.9%), the wearable technology increased motivation to do activity (87.5%), and the community workshops were beneficial (75%). Across all participants, there was an average daily increase of 9.8 (27.8) min/day MVPA following the intervention. The greatest increase in MVPA was observed in the W-APP-C group (15.5 (23.1) min/day), followed by the APP group (11.4 (25.5) min/day), and the W-APP group 2.6 (32.1) min/day.
Conclusions
This multi-centre randomised controlled feasibility trial highlights the feasibility and acceptability of a wearable-based micropattern intervention in women from socioeconomically and culturally diverse backgrounds.
Competing Interest Statement
ES is a paid consultant and holds equity in Complement 1, a US-based company whose products and services relate to healthy lifestyles. All other authors disclose no conflict of interest for this work.
Funding Statement
This study was funded by The University of Glasgow and University of Sydney Health Inequalities Initiative (227213) and an Australian National Health and Medical Research Council (NHMRC) Investigator Grant (APP1194510).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants provided either written or digital consent to participation in this study, and the project was approved by ethics committees in both the UK (University of Glasgow, College of Medicine, Veterinary and Life Sciences College Ethics Committee: 200240234) and Australia (The University of Sydney, Human Research and Ethics Committee: HEOO1729).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Joint first
↵† joint senior authors
Professor Mark Hamer, a Chief Investigator on the project, was inadvertently omitted from the original author list. As a core member of the research team who has made substantial contributions to the development and conceptualisation of the study, his inclusion as a co-author is both appropriate and warranted.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.